Traffic:
10E
10W
15N
15S
57N
57S
60E
60W
210E
210W
This Site
Web Search
powered by
YAHOO! SEARCH
Subscriber Services
|
Home Delivery
|
e-Edition
|
Alerts
|
RSS
Home
News
Ontario
Rancho Cucamonga
Pomona
Upland
Claremont
Montclair
Chino Valley
California
Crime & Public Safety
Elections
Education
S.B. County Watch
Upland Watch
I.E.: Medicare Testing Ground
Sports
Buy Event Tickets Now
Golf - Tee Times and Courses
Preps
Reign Hockey
Rancho Cucamonga Quakes
Local Colleges
USC
UCLA
Lakers
Clippers
Dodgers
Angels
Ducks
Soccer
Motor Sports
Horse Racing
Live Odds
Business
Autos
Real Estate News
Technology
Opinions
Editorial
Letters
Columnists
Blogs
LA.COM
Buy Tickets
Movies
TV
Music
Shopping & Beauty
Recreation
Neighborhood
Arts
Living
Dining
Find A Restaurant
Lottery
Horoscopes
Travel
Trevor's Travels
Health
Crossword Puzzle
Local Casinos
Foothills Magazine
Info
Subscribe For Home Delivery
Contact Us
RSS
Podcast
Subscriber Services
Place An Ad
NIE
Classified
Place an Ad
Homes
Jobs
Auto
Search autos
Buy/Sell a car
Research/Financing a car
Find a dealer
Shopping
This week's ads
Obits
Directories
Local Business
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about alzheimer's
Recent news which mentions alzheimer's
Cassava Sciences Cooperates With DOJ, SEC On Controversial Alzheimer's Drug Investigation
July 01, 2024
Tickers
NEWS
SAVA
Tags
Legal
General
alzheimer's
From
Benzinga
Alzheimer's Drug Trial Results Questioned After 'Damning' FDA Inspection Report
March 11, 2024
Tickers
NEWS
SAVA
Tags
Market News
Food and Drug Administration
alzheimer's
From
Benzinga
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
November 21, 2023
Tickers
ACIU
BIIB
ESAIY
ESALY
Tags
Benzinga
Biotech
VAXX
From
Benzinga
FDA Approves Biogen's Alzheimer's Drug: Here Are Other Companies With Treatments In The Pipeline
July 07, 2023
Tickers
ALZN
BIIB
LLY
SAVA
Tags
SAVA
Alzheimer's disease
Benzinga
From
Benzinga
Tesla, Amazon, Microsoft, Cassava Sciences, Intuitive Surgical: Why These 5 Stocks Are Drawing Investors' Attention Today
January 24, 2023
Tickers
AMZN
ISRG
MSFT
SAVA
Tags
Markets
Market News
AMZN
From
Benzinga
Psychedelics For Alzheimer's And Stress-Induced Disorders Under Study At Columbia University
October 18, 2022
Tickers
SILO
Tags
Psilocybin
Markets
Cannabis
From
Benzinga
Nasdaq Futures Slip But S&P 500, Dow Futures Hold Up Ahead Of Market Open — Apple, Biogen Stocks In Focus
September 28, 2022
Tickers
AAPL
BIIB
QQQ
SPY
Tags
Biotech
Benzinga
AAPL
From
Benzinga
Why Biogen Stock Is Up 40% Today
September 28, 2022
Tickers
BIIB
ESALY
Tags
News
Trading Ideas
BIIB
From
Benzinga
Brain Awareness Month: Bittersweet glimpse into early-dementia via video by Entertainer Carissa Biele
June 21, 2022
Tickers
VNUE
Tags
country
vnue
Entertainment
From
PRUnderground
Benzinga's Daily Brief On Trending Tickers For April 19, 2022: Plug Power, Twitter, Cassava Sciences And More
April 19, 2022
Tickers
AXSM
JNJ
PLUG
RBLX
Tags
Trading Ideas
AXSM
JNJ
From
Benzinga
IGC THC-Drug For Alzheimer's Symptoms Proved Safe & Effective, Pending FDA Approval For More Trials
December 14, 2021
Tickers
IGC
THC
Tags
Biotech
Benzinga
IGC
From
Benzinga
The Walk To End Alzheimer’s Partnership
November 01, 2021
Tags
Small Business
Alzheimer's
Photo Scanning
From
PRUnderground
Digital therapeutics startup Neuroglee raises $10M to help people with neurodegenerative conditions
September 09, 2021
Tickers
ASIA
TC
Tags
Neuroglee Therapeutics
Alzheimer's
Singapore
From
TechCrunch
FDA Narrows Label To Recommend Use Of Biogen's Aduhelm In Mild Alzheimer's Patients
July 08, 2021
Tickers
BIIB
ESALY
Tags
Market News
General
BIIB
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Privacy Policy
|
Terms of Use
|
MNG Corporate Site Map
|
Copyright